NCT01558934View on ClinicalTrials.gov

Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Opioid DependenceMethadone Withdrawal Syndrome
Interventions
DRUG

Lofexidine HCl

Lofexidine HCl 0.2 mg tablets titrated in ascending doses of 0.2 mg QID (e.g. Day 1 0.2 mg QID, Day 2 0.4 QID, etc)as described in the treatment arm.

Trial Locations (1)

84106

Lifetree Clinical Research, Salt Lake City

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

USWM, LLC (dba US WorldMeds)

INDUSTRY

NCT01558934 - Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients | Biotech Hunter | Biotech Hunter